-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M1TEhYfJjkDJeiqgHBUMqMW/epKz/t8GbtQDXAUnQOcZX1R6Eid1HkHv1VOCz8Yn vbGoMggXCYElbqAX77soGQ== 0001144204-08-021541.txt : 20080410 0001144204-08-021541.hdr.sgml : 20080410 20080410141928 ACCESSION NUMBER: 0001144204-08-021541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071017 FILED AS OF DATE: 20080410 DATE AS OF CHANGE: 20080410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Advaxis, Inc. CENTRAL INDEX KEY: 0001100397 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841521955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 675 ROUTE 1 STREET 2: SUITE B 113 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 732 545 1590 MAIL ADDRESS: STREET 1: 675 ROUTE 1 STREET 2: SUITE B 113 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 FORMER COMPANY: FORMER CONFORMED NAME: GREAT EXPECTATIONS & ASSOCIATES INC DATE OF NAME CHANGE: 19991203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKEARN THOMAS J CENTRAL INDEX KEY: 0001022849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28489 FILM NUMBER: 08749653 BUSINESS ADDRESS: STREET 1: CO/CYTOGEN CORPORATION STREET 2: 600 COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099878230 MAIL ADDRESS: STREET 1: CO/CYTOGEN CORPORATION STREET 2: 600 COLLEGE RD CITY: PRINCETON STATE: NJ ZIP: 19044 4 1 v110293_ex.xml X0202 4 2007-10-17 0 0001100397 Advaxis, Inc. ADXS 0001022849 MCKEARN THOMAS J C/O ADVAXIS, INC. TECHNOLOGY CENTER OF NJ, 675 US HWY ONE NORTH BRUNSWICK NJ 08902 1 0 0 0 Warrant 0.40 2007-10-17 4 D 0 90549 A 2004-11-12 2009-11-12 Common Stock 90549 22274 D Warrant 0.274 2007-10-17 4 A 0 131969 A 2004-11-12 2009-11-12 Common Stock 131969 154243 D The two reported transactions involved an anti-dilution adjustment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the deemed grant of a replacement warrant. The adjustment was necessary because the anti-dilution provision in the "old" warrant was triggered by a subsequent warrant issuance by the Issuer, resulting in a new exercise price and a change in the amount of shares underlying the warrants. This total includes 22,274 shares of common stock issuable upon the exercise of warrants as previously reported with the Securities and Exchange Commission on November 16, 2004. /s/ Thomas McKearn 2008-04-10 -----END PRIVACY-ENHANCED MESSAGE-----